Tag Archives: Sativex

London-based GW Pharmaceuticals PLC (NASDAQ: GWPH) released its second-quarter financial report for fiscal 2016 on Thursday. The company, arguably the most well recognized pharma in the cannabis space, was applauded by the markets in March for its drug development efforts with a spike in value from around $36 to a …